Albumin orchestrates a natural host defense mechanism against mucormycosis
2024

Albumin's Role in Fighting Mucormycosis

Sample size: 97 publication 10 minutes Evidence: high

Author Information

Author(s): Chamilos Georgios, Pikoulas Antonis, Morianos Ioannis, Nidris Vassilis, Hamdy Rania, López-López Angeles, Moran-Garrido Maria, Muthu Valliappan, Halabalaki Maria, Papadovasilaki Maria, Irene Kyrmizi, Gu Yiyou, Aerts Robina, Mercier Toine, Vanbiervliet Yuri, Cho Sung-Yeon, Spallone Amy, Samonakis Dimitrios, Kastritis Efstathios, Drakos Elias, Tzardi Maria, Eliopoulos Aristides, Georgila Konstantina, Carvalho Agostinho, Kurzai Oliver, Rudramurthy Shivaprakash, Lanternier Fanny, Petratos Kyriacos, Maertens Johan, Bruno Vincent, Kontoyiannis Dimitrios, Barbas Coral, Soliman Sameh, Ibrahim Ashraf

Primary Institution: Institute of Molecular Biology and Biotechnology, FORTH, Hellas

Hypothesis

Uncharacterized host metabolic effectors confer protective immunity against mucormycosis.

Conclusion

Albumin plays a crucial role in inhibiting the growth of Mucorales and modulating their pathogenicity.

Supporting Evidence

  • Severe hypoalbuminemia is a prominent metabolic abnormality in mucormycosis patients.
  • Purified albumin selectively inhibits Mucorales growth.
  • Albumin-deficient mice show increased susceptibility to mucormycosis.
  • Albumin-bound free fatty acids (FFAs) are crucial for antifungal activity.
  • High levels of oxidized FFAs correlate with poor outcomes in mucormycosis patients.
  • Albumin prevents FFA oxidation, maintaining their antifungal properties.
  • Albumin modulates the expression of virulence factors in Mucorales.
  • Restoring albumin levels improves resistance to mucormycosis in animal models.

Takeaway

Albumin helps our body fight off a dangerous fungus called Mucorales by stopping it from growing and causing harm.

Methodology

The study involved analyzing serum albumin levels and their antifungal activity against Mucorales in various patient cohorts.

Potential Biases

Potential biases may arise from the retrospective nature of patient data collection.

Limitations

The study primarily focused on specific patient populations, which may limit the generalizability of the findings.

Participant Demographics

Patients with hematological malignancies and metabolic disorders, including diabetes and COVID-19.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.21203/rs.3.rs-5441197

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication